StockData
Ascend Wellness Holdings, Inc. logo

Ascend Wellness Holdings, Inc. (AAWH) stock

AAWHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$0.39−0.00 (-0.73%)

Close on Oct 19, 2026Market cap $79.60MP/E –Yield –

Ascend Wellness operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Ascend Wellness's operating income for the twelve months ending Jun 30, 2026 was -$10.67M, down 306.6% year over year. For fiscal 2025 it was -$17.01M, down 459.4% from the year before. The highest annual figure on record is $7.85M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.01M-459.4%
FY2024Dec 31, 2024$4.73M–
FY2023Dec 31, 2023-$3.62M–
FY2022Dec 31, 2022-$7.53M–
FY2021Dec 31, 2021-$17.20M-319.2%
FY2020Dec 31, 2020$7.85M–
FY2019Dec 31, 2019-$26.12M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.28M–
Q1 FY2026Mar 31, 2026$2.55M+2.4%
Q4 FY2025Dec 31, 2025-$17.17M-381.6%
Q3 FY2025Sep 30, 2025-$1.33M–
Q2 FY2025Jun 30, 2025-$1.00M–
Q1 FY2025Mar 31, 2025$2.49M-3.5%
Q4 FY2024Dec 31, 2024$6.10M+981.2%
Q3 FY2024Sep 30, 2024-$2.42M-168.1%
Q2 FY2024Jun 30, 2024-$1.52M–
Q1 FY2024Mar 31, 2024$2.58M+909.8%
Q4 FY2023Dec 31, 2023$564.00K-89.5%
Q3 FY2023Sep 30, 2023$3.55M+43.2%
Q2 FY2023Jun 30, 2023-$7.99M–
Q1 FY2023Mar 31, 2023$255.00K–
Q4 FY2022Dec 31, 2022$5.38M–
Q3 FY2022Sep 30, 2022$2.48M-78.7%
Q2 FY2022Jun 30, 2022-$605.00K-115.5%
Q1 FY2022Mar 31, 2022-$14.78M–
Q4 FY2021Dec 31, 2021-$731.00K-116.4%
Q3 FY2021Sep 30, 2021$11.61M+246.4%
Q2 FY2021Jun 30, 2021$3.90M+77.2%
Q1 FY2021Mar 31, 2021-$31.99M–
Q4 FY2020Dec 31, 2020$4.45M–
Q3 FY2020Sep 30, 2020$3.35M–
Q2 FY2020Jun 30, 2020$2.20M–
Q1 FY2020Mar 31, 2020-$2.16M–

More Ascend Wellness figures

See a number that looks wrong?